|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Epstein-Barr Virus (VCA) IgG ELISA | Alpha2,6-Sialyltransferase ( Alpha2,6-ST) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | IGFBP-2 ELISA Assay | Lysozyme ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79861 | 27762 | TM09036 | E05 | IB19131 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The Epstein-Barr Virus (VCA) IgG ELISA is intended for the determination of IgG class antibodies against Epstein-Barr Virus viral capsid antigen (VCA) in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination each of human, rat and mouse a 2,6-sialyltransferase in serum, EDTA plasma and cell culture supernatant. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the determination of human IGFBP-2 in human serum, EDTA-plasma, cerebrospinal fluid, breast milk, amniotic fluid, saliva, and in cell culture medium. For research use only, not for use in diagnostic procedures. | Solid phase direct sandwich ELISA for the determination of Lysozyme in human plasma, serum, or stool. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Thioredoxin | Calcitonin | sAPP Total | Corticosterone | Human T-Cadherin(130K) |
| Sample Type | Serum, Blood Plasma, Urine, Cell Culture Supernatant | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Human serum and EDTA-plasma. |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | 1.09 to 70 ng/mL | Anti-Ustekinumab (Stelara®) | 2 to 80 ng/mL | 0.1 to 40.0 ng/mL |
| Sensitivity | 0.43 ng/mL | 1.0 pg/mL | 0.06 ng/mL | < 1.63 nmol/L | 0.01 ng/mL |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hrs (incubation) | 2 hour, 30 min. total incubation time. | 1 hr 45 mins (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |